-
1
-
-
0038328957
-
Pharmacological approaches to reducing allogeneic blood exposure
-
Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang 2003;84:2-10
-
(2003)
Vox Sang
, vol.84
, pp. 2-10
-
-
Kovesi, T.1
Royston, D.2
-
2
-
-
0028792021
-
A multicenter, double-blind, placebocontrolled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting
-
Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J, Clark RE, Smith P, Nadel A, Bonney SL, Kleinfield R. A multicenter, double-blind, placebocontrolled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92:2236-44
-
(1995)
Circulation
, vol.92
, pp. 2236-2244
-
-
Levy, J.H.1
Pifarre, R.2
Schaff, H.V.3
Horrow, J.C.4
Albus, R.5
Spiess, B.6
Rosengart, T.K.7
Murray, J.8
Clark, R.E.9
Smith, P.10
Nadel, A.11
Bonney, S.L.12
Kleinfield, R.13
-
3
-
-
0029958434
-
The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery
-
D'Errico CC, Shayevitz JR, Martindale SJ, Mosca RS, Bove EL. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996;83:1193-9
-
(1996)
Anesth Analg
, vol.83
, pp. 1193-1199
-
-
D'Errico, C.C.1
Shayevitz, J.R.2
Martindale, S.J.3
Mosca, R.S.4
Bove, E.L.5
-
4
-
-
0037314646
-
High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery
-
Mossinger H, Dietrich W, Braun SL, Jochum M, Meisner H, Richter JA. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003;75:430-7
-
(2003)
Ann Thorac Surg
, vol.75
, pp. 430-437
-
-
Mossinger, H.1
Dietrich, W.2
Braun, S.L.3
Jochum, M.4
Meisner, H.5
Richter, J.A.6
-
5
-
-
31344467254
-
The risk associated with aprotinin in cardiac surgery
-
Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65
-
(2006)
N Engl J Med
, vol.354
, pp. 353-365
-
-
Mangano, D.T.1
Tudor, I.C.2
Dietzel, C.3
-
6
-
-
33644680067
-
A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
-
Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006;46:327-38
-
(2006)
Transfusion
, vol.46
, pp. 327-338
-
-
Karkouti, K.1
Beattie, W.S.2
Dattilo, K.M.3
McCluskey, S.A.4
Ghannam, M.5
Hamdy, A.6
Wijeysundera, D.N.7
Fedorko, L.8
Yau, T.M.9
-
7
-
-
33846885901
-
Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery
-
Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007;297:471-9
-
(2007)
JAMA
, vol.297
, pp. 471-479
-
-
Mangano, D.T.1
Miao, Y.2
Vuylsteke, A.3
Tudor, I.C.4
Juneja, R.5
Filipescu, D.6
Hoeft, A.7
Fontes, M.L.8
Hillel, Z.9
Ott, E.10
Titov, T.11
Dietzel, C.12
Levin, J.13
-
8
-
-
67649145749
-
-
Bayer Healthcare Pharmaceuticals communication (Leverkusen, Germany and West Haven, CT, USA): Available at: www.trasylol. com; www.pharma.bayer.com; www.bayerscheringpharma.de/ trasylol/en, www.bayerhealthcare.com/trasylol/en.
-
Bayer Healthcare Pharmaceuticals communication (Leverkusen, Germany and West Haven, CT, USA): Available at: www.trasylol. com; www.pharma.bayer.com; www.bayerscheringpharma.de/ trasylol/en, www.bayerhealthcare.com/trasylol/en.
-
-
-
-
9
-
-
0031057055
-
Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations
-
Davies MJ, Allen A, Kort H, Weerasena NA, Rocco D, Paul CL, Hunt BJ, Elliott MJ. Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997;63:497-503
-
(1997)
Ann Thorac Surg
, vol.63
, pp. 497-503
-
-
Davies, M.J.1
Allen, A.2
Kort, H.3
Weerasena, N.A.4
Rocco, D.5
Paul, C.L.6
Hunt, B.J.7
Elliott, M.J.8
-
10
-
-
0031663326
-
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations
-
Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998;66:535-41
-
(1998)
Ann Thorac Surg
, vol.66
, pp. 535-541
-
-
Miller, B.E.1
Tosone, S.R.2
Tam, V.K.3
Kanter, K.R.4
Guzzetta, N.A.5
Bailey, J.M.6
Levy, J.H.7
-
11
-
-
33644534151
-
Avoiding transfusions in children undergoing cardiac surgery: A meta-analysis of randomized trials of aprotinin
-
Arnold DM, Fergusson DA, Chan AKC, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006;102:731-7
-
(2006)
Anesth Analg
, vol.102
, pp. 731-737
-
-
Arnold, D.M.1
Fergusson, D.A.2
Chan, A.K.C.3
Cook, R.J.4
Fraser, G.A.5
Lim, W.6
Blajchman, M.A.7
Cook, D.J.8
-
12
-
-
0036383276
-
Consensus-based method for risk adjustment for surgery for congenital heart disease
-
Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002;123:110-8
-
(2002)
J Thorac Cardiovasc Surg
, vol.123
, pp. 110-118
-
-
Jenkins, K.J.1
Gauvreau, K.2
Newburger, J.W.3
Spray, T.L.4
Moller, J.H.5
Iezzoni, L.I.6
-
13
-
-
10244236377
-
-
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004;8:R204-R12
-
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004;8:R204-R12
-
-
-
-
14
-
-
0025142843
-
Aprotinin in paediatric cardiac surgery
-
Elliot MJ, Allen A. Aprotinin in paediatric cardiac surgery. Perfusion 1990;5:73-6
-
(1990)
Perfusion
, vol.5
, pp. 73-76
-
-
Elliot, M.J.1
Allen, A.2
-
15
-
-
0037385540
-
Aprotinin reduces operative closure time and blood product use after pediatric bypass
-
Costello JM, Backer CL, de Hoyos A, Binns HJ, Mavroudis C. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 2003;75:1261-6
-
(2003)
Ann Thorac Surg
, vol.75
, pp. 1261-1266
-
-
Costello, J.M.1
Backer, C.L.2
de Hoyos, A.3
Binns, H.J.4
Mavroudis, C.5
-
16
-
-
0025995998
-
The effects of aprotinin on hemostatic function during cardiac surgery
-
Marx G, Pokar H, Reuter H, Doering V, Tilsner V. The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothorac Vasc Anesth 1991;5:467-74
-
(1991)
J Cardiothorac Vasc Anesth
, vol.5
, pp. 467-474
-
-
Marx, G.1
Pokar, H.2
Reuter, H.3
Doering, V.4
Tilsner, V.5
-
17
-
-
0026053027
-
Hemostasis in patients undergoing extracorporeal circulation: The effect of aprotinin (Trasylol)
-
Lu H, Soria C, Commin PL, Soria J, Piwnica A, Schumann F, Regnier O, Legrand Y, Caen JP. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol). Thromb Haemost 1991;66:633-7
-
(1991)
Thromb Haemost
, vol.66
, pp. 633-637
-
-
Lu, H.1
Soria, C.2
Commin, P.L.3
Soria, J.4
Piwnica, A.5
Schumann, F.6
Regnier, O.7
Legrand, Y.8
Caen, J.P.9
-
18
-
-
0027173089
-
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations
-
Dietrich W, Mossinger H, Spannagl M, Jochum M, Wendt P, Barankay A, Meisner H, Richter JA. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 1993;105:712-20
-
(1993)
J Thorac Cardiovasc Surg
, vol.105
, pp. 712-720
-
-
Dietrich, W.1
Mossinger, H.2
Spannagl, M.3
Jochum, M.4
Wendt, P.5
Barankay, A.6
Meisner, H.7
Richter, J.A.8
-
19
-
-
0032126606
-
Aprotinin in pediatric cardiac operations: A benefit in complex malformations and with high-dose regimen only
-
Carrel TP, Schwanda M, Vogt PR, Turina MI. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg 1998;66:153-8
-
(1998)
Ann Thorac Surg
, vol.66
, pp. 153-158
-
-
Carrel, T.P.1
Schwanda, M.2
Vogt, P.R.3
Turina, M.I.4
-
20
-
-
0029436203
-
Aprotinin in children undergoing repair of congenital heart defects
-
Penkoske PA, Entwistle LM, Marchak BE, Seal RF, Gibb W. Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac Surg 1995;60:S529-S32
-
(1995)
Ann Thorac Surg
, vol.60
-
-
Penkoske, P.A.1
Entwistle, L.M.2
Marchak, B.E.3
Seal, R.F.4
Gibb, W.5
-
21
-
-
0033406627
-
Pro: The routine use of aprotinin during pediatric cardiac surgery is a benefit
-
D'Errico CC, Munro HM, Bove EL. Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit. J Cardiothorac Vasc Anesth 1999;13:782-4
-
(1999)
J Cardiothorac Vasc Anesth
, vol.13
, pp. 782-784
-
-
D'Errico, C.C.1
Munro, H.M.2
Bove, E.L.3
-
22
-
-
34250865815
-
Cytokine secretion after cardiac surgery and its relationship to postoperative fever
-
Mitchell JD, Grocott HP, Phillips-Bute B, Mathew JP, Newman MF, Bar-Yosef S. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine 2007;38:37-42
-
(2007)
Cytokine
, vol.38
, pp. 37-42
-
-
Mitchell, J.D.1
Grocott, H.P.2
Phillips-Bute, B.3
Mathew, J.P.4
Newman, M.F.5
Bar-Yosef, S.6
-
23
-
-
33747105315
-
Cytokine response in children undergoing surgery for congenital heart disease
-
Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006; 27:408-13
-
(2006)
Pediatr Cardiol
, vol.27
, pp. 408-413
-
-
Madhok, A.B.1
Ojamaa, K.2
Haridas, V.3
Parnell, V.A.4
Pahwa, S.5
Chowdhury, D.6
|